Wanbangde Pharmaceutical Holding Group Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 727.24 million compared to CNY 927.37 million a year ago. Revenue was CNY 731.17 million compared to CNY 928.67 million a year ago.

Net income was CNY 58.1 million compared to CNY 112.25 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.18 a year ago.